Share Price and Basic Stock Data
Last Updated: January 8, 2026, 7:14 pm
| PEG Ratio | 0.52 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
AccelerateBS India Ltd operates in the IT Consulting and Software industry, with a market capitalization of ₹29.2 Cr and a current share price of ₹84.9. The company reported sales of ₹2.80 Cr for the year ending March 2023, which increased to ₹6.78 Cr by March 2024. However, the sales slightly declined to ₹6.77 Cr in March 2025, indicating a volatile revenue trend. The trailing twelve months (TTM) revenue stood at ₹6.90 Cr, showcasing the company’s capacity to generate consistent income despite fluctuations. The operating profit margin (OPM) recorded for March 2023 was 24.29%, which peaked at 28.17% in March 2024 but subsequently fell to 18.61% by March 2025. The company’s sales figures demonstrate its ability to capture market share, although the decline in OPM may raise concerns about cost management and competitive positioning in the IT sector.
Profitability and Efficiency Metrics
Profitability metrics for AccelerateBS India Ltd reveal a mixed performance. The net profit for March 2023 was ₹0.39 Cr, which plummeted to ₹0.03 Cr by March 2024, yet rebounded to ₹0.73 Cr in March 2025. The earnings per share (EPS) reflected this trend, with figures of ₹1.26 in March 2023, rising to ₹2.12 by March 2025. The return on equity (ROE) stood at 17.6%, and return on capital employed (ROCE) was reported at 22.2%, indicating effective use of shareholder funds and capital. The cash conversion cycle (CCC) of 106.21 days suggests moderate efficiency in managing working capital. The interest coverage ratio (ICR) reported an impressive 568.86x, highlighting robust capacity to cover interest expenses, positioning the company favorably against industry norms.
Balance Sheet Strength and Financial Ratios
AccelerateBS India Ltd exhibits a strong balance sheet with total assets reported at ₹7.05 Cr and negligible borrowings of ₹0.02 Cr as of March 2025. This reflects a solid financial foundation and minimal reliance on debt. The company’s reserves stood at ₹1.73 Cr, providing a buffer for future growth and investment. The current ratio of 10.62x signifies excellent liquidity, well above the typical industry benchmark of around 1.5x, indicating that the company can easily meet its short-term obligations. However, the price-to-book value (P/BV) ratio of 9.94x suggests that the stock may be overvalued relative to its book value, a concern for potential investors. Overall, the financial ratios indicate prudent financial management and an ability to sustain operations without excessive leverage.
Shareholding Pattern and Investor Confidence
The shareholding pattern of AccelerateBS India Ltd reveals a strong promoter presence, holding 71.02% as of September 2025, which fosters investor confidence. The public shareholding stands at 28.99%, with a total of 357 shareholders recorded. The gradual increase in the number of shareholders from 197 in September 2023 to 357 in September 2025 indicates growing interest in the company. This trend may reflect confidence in the company’s strategic direction and financial performance. However, the lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could limit broader market support. The high promoter holding, while generally positive, also raises concerns regarding governance and liquidity, as a concentrated ownership structure may deter new investors from entering.
Outlook, Risks, and Final Insight
The outlook for AccelerateBS India Ltd appears cautiously optimistic, given its strong financial metrics and growing sales. However, risks include fluctuating profitability, as evidenced by the net profit decline in March 2024, which could impact investor sentiment. Additionally, the volatility in OPM raises questions about operational efficiency and competitive pressures in the IT consulting sector. The company’s high P/BV ratio may deter value-focused investors, while reliance on a concentrated promoter base could pose governance challenges. Nevertheless, if the company can stabilize its earnings and manage costs effectively, it may present a compelling investment opportunity. Future strategies aimed at diversifying its revenue streams and attracting institutional investors could enhance its market position and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 3.55 Cr. | 236 | 236/103 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.2 Cr. | 22.3 | 22.3/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 128 Cr. | 78.7 | 101/18.4 | 62.7 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 10.6 Cr. | 36.6 | 64.9/33.1 | 7.18 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 27.2 Cr. | 79.0 | 165/67.0 | 18.5 | 15.0 | 1.27 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 122,363.38 Cr | 850.87 | 47.24 | 158.22 | 0.75% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Sales | 2.80 | 2.71 | 4.08 | 3.24 | 3.53 | 3.37 |
| Expenses | 2.09 | 2.16 | 2.74 | 3.02 | 2.55 | 2.18 |
| Operating Profit | 0.71 | 0.55 | 1.34 | 0.22 | 0.98 | 1.19 |
| OPM % | 25.36% | 20.30% | 32.84% | 6.79% | 27.76% | 35.31% |
| Other Income | 0.04 | -0.89 | 0.01 | 0.02 | 0.03 | 0.07 |
| Interest | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 |
| Depreciation | 0.06 | 0.07 | 0.07 | 0.06 | 0.08 | 0.05 |
| Profit before tax | 0.65 | -0.42 | 1.28 | 0.18 | 0.93 | 1.19 |
| Tax % | 10.77% | 30.95% | 53.12% | 27.78% | 35.48% | 26.05% |
| Net Profit | 0.58 | -0.56 | 0.59 | 0.13 | 0.60 | 0.87 |
| EPS in Rs | 1.87 | -1.65 | 1.74 | 0.38 | 1.75 | 2.53 |
Last Updated: December 28, 2025, 10:01 am
Below is a detailed analysis of the quarterly data for AccelerateBS India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3.37 Cr.. The value appears to be declining and may need further review. It has decreased from 3.53 Cr. (Mar 2025) to 3.37 Cr., marking a decrease of 0.16 Cr..
- For Expenses, as of Sep 2025, the value is 2.18 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.55 Cr. (Mar 2025) to 2.18 Cr., marking a decrease of 0.37 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.19 Cr.. The value appears strong and on an upward trend. It has increased from 0.98 Cr. (Mar 2025) to 1.19 Cr., marking an increase of 0.21 Cr..
- For OPM %, as of Sep 2025, the value is 35.31%. The value appears strong and on an upward trend. It has increased from 27.76% (Mar 2025) to 35.31%, marking an increase of 7.55%.
- For Other Income, as of Sep 2025, the value is 0.07 Cr.. The value appears strong and on an upward trend. It has increased from 0.03 Cr. (Mar 2025) to 0.07 Cr., marking an increase of 0.04 Cr..
- For Interest, as of Sep 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.08 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.03 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.19 Cr.. The value appears strong and on an upward trend. It has increased from 0.93 Cr. (Mar 2025) to 1.19 Cr., marking an increase of 0.26 Cr..
- For Tax %, as of Sep 2025, the value is 26.05%. The value appears to be improving (decreasing) as expected. It has decreased from 35.48% (Mar 2025) to 26.05%, marking a decrease of 9.43%.
- For Net Profit, as of Sep 2025, the value is 0.87 Cr.. The value appears strong and on an upward trend. It has increased from 0.60 Cr. (Mar 2025) to 0.87 Cr., marking an increase of 0.27 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.53. The value appears strong and on an upward trend. It has increased from 1.75 (Mar 2025) to 2.53, marking an increase of 0.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:20 am
| Metric | Mar 2023n n 7m | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Sales | 2.80 | 6.78 | 6.77 | 6.90 |
| Expenses | 2.12 | 4.87 | 5.51 | 4.73 |
| Operating Profit | 0.68 | 1.91 | 1.26 | 2.17 |
| OPM % | 24.29% | 28.17% | 18.61% | 31.45% |
| Other Income | 0.07 | -0.89 | 0.05 | 0.10 |
| Interest | 0.05 | 0.02 | 0.06 | 0.02 |
| Depreciation | 0.06 | 0.15 | 0.14 | 0.13 |
| Profit before tax | 0.64 | 0.85 | 1.11 | 2.12 |
| Tax % | 40.62% | 97.65% | 34.23% | |
| Net Profit | 0.39 | 0.03 | 0.73 | 1.47 |
| EPS in Rs | 1.26 | 0.09 | 2.12 | 4.28 |
| Dividend Payout % | 0.00% | 0.00% | 47.12% |
YoY Net Profit Growth
| Year | 2024-2025 |
|---|---|
| YoY Net Profit Growth (%) | 2333.33% |
| Change in YoY Net Profit Growth (%) | 0.00% |
AccelerateBS India Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: December 10, 2025, 3:43 am
| Month | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|
| Equity Capital | 1.96 | 2.15 | 3.44 | 3.44 |
| Reserves | 0.22 | 1.76 | 0.93 | 1.73 |
| Borrowings | 0.33 | 0.54 | 1.73 | 0.02 |
| Other Liabilities | 0.40 | 0.40 | 0.95 | 1.46 |
| Total Liabilities | 2.91 | 4.85 | 7.05 | 6.65 |
| Fixed Assets | 0.51 | 0.40 | 0.33 | 1.39 |
| CWIP | 0.00 | 0.00 | 0.59 | 0.00 |
| Investments | 0.60 | 0.00 | 0.00 | 0.03 |
| Other Assets | 1.80 | 4.45 | 6.13 | 5.23 |
| Total Assets | 2.91 | 4.85 | 7.05 | 6.65 |
Below is a detailed analysis of the balance sheet data for AccelerateBS India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.44 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.44 Cr..
- For Reserves, as of Sep 2025, the value is 1.73 Cr.. The value appears strong and on an upward trend. It has increased from 0.93 Cr. (Mar 2025) to 1.73 Cr., marking an increase of 0.80 Cr..
- For Borrowings, as of Sep 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1.73 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 1.71 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.46 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.95 Cr. (Mar 2025) to 1.46 Cr., marking an increase of 0.51 Cr..
- For Total Liabilities, as of Sep 2025, the value is 6.65 Cr.. The value appears to be improving (decreasing). It has decreased from 7.05 Cr. (Mar 2025) to 6.65 Cr., marking a decrease of 0.40 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1.39 Cr.. The value appears strong and on an upward trend. It has increased from 0.33 Cr. (Mar 2025) to 1.39 Cr., marking an increase of 1.06 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.59 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.59 Cr..
- For Investments, as of Sep 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Other Assets, as of Sep 2025, the value is 5.23 Cr.. The value appears to be declining and may need further review. It has decreased from 6.13 Cr. (Mar 2025) to 5.23 Cr., marking a decrease of 0.90 Cr..
- For Total Assets, as of Sep 2025, the value is 6.65 Cr.. The value appears to be declining and may need further review. It has decreased from 7.05 Cr. (Mar 2025) to 6.65 Cr., marking a decrease of 0.40 Cr..
Notably, the Reserves (1.73 Cr.) exceed the Borrowings (0.02 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
Free Cash Flow
| Month | Mar 2023n n 7m | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Free Cash Flow | 0.68 | 1.37 | -0.47 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 110.80 | 103.90 | 106.21 |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 110.80 | 103.90 | 106.21 |
| Working Capital Days | 79.52 | 108.21 | 115.38 |
| ROCE % | 51.15% | 22.18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.57 | 0.15 | 1.97 | 2.57 | 4.22 |
| Diluted EPS (Rs.) | 2.57 | 0.15 | 1.97 | 2.57 | 4.22 |
| Cash EPS (Rs.) | 2.53 | 0.81 | 2.25 | 2.96 | 4.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 12.70 | 18.18 | 11.11 | 10.00 | 10.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 12.70 | 18.18 | 11.11 | 10.00 | 10.00 |
| Dividend / Share (Rs.) | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 19.69 | 31.59 | 14.26 | 31.72 | 43.92 |
| PBDIT / Share (Rs.) | 3.64 | 8.94 | 3.81 | 4.29 | 6.79 |
| PBIT / Share (Rs.) | 3.24 | 8.26 | 3.53 | 3.66 | 6.08 |
| PBT / Share (Rs.) | 3.23 | 3.97 | 3.30 | 3.42 | 6.04 |
| Net Profit / Share (Rs.) | 2.13 | 0.14 | 1.97 | 2.33 | 4.15 |
| PBDIT Margin (%) | 18.48 | 28.28 | 26.73 | 13.51 | 15.47 |
| PBIT Margin (%) | 16.46 | 26.14 | 24.74 | 11.54 | 13.83 |
| PBT Margin (%) | 16.43 | 12.56 | 23.11 | 10.78 | 13.75 |
| Net Profit Margin (%) | 10.82 | 0.44 | 13.79 | 7.35 | 9.45 |
| Return on Networth / Equity (%) | 16.79 | 0.78 | 17.70 | 23.33 | 41.50 |
| Return on Capital Employeed (%) | 17.19 | 37.65 | 27.91 | 29.61 | 60.62 |
| Return On Assets (%) | 10.39 | 0.62 | 13.23 | 12.91 | 23.50 |
| Long Term Debt / Equity (X) | 0.39 | 0.13 | 0.11 | 0.23 | 0.00 |
| Total Debt / Equity (X) | 0.39 | 0.13 | 0.11 | 0.40 | 0.23 |
| Asset Turnover Ratio (%) | 1.14 | 1.75 | 1.14 | 1.85 | 2.94 |
| Current Ratio (X) | 10.62 | 31.14 | 4.13 | 2.63 | 1.81 |
| Quick Ratio (X) | 10.62 | 31.14 | 4.13 | 2.63 | 1.81 |
| Dividend Payout Ratio (NP) (%) | 37.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 31.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 62.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 68.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 568.86 | 202.15 | 16.40 | 17.82 | 193.42 |
| Interest Coverage Ratio (Post Tax) (X) | 334.18 | 100.28 | 9.46 | 10.70 | 119.14 |
| Enterprise Value (Cr.) | 41.82 | 65.99 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 6.18 | 9.72 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 33.41 | 34.36 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 6.41 | 9.97 | 0.00 | 0.00 | 0.00 |
| Retention Ratios (%) | 62.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 9.94 | 17.32 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 6.41 | 9.97 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for AccelerateBS India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 24) to 2.57, marking an increase of 2.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 24) to 2.57, marking an increase of 2.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.53. This value is below the healthy minimum of 3. It has increased from 0.81 (Mar 24) to 2.53, marking an increase of 1.72.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.70. It has decreased from 18.18 (Mar 24) to 12.70, marking a decrease of 5.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.70. It has decreased from 18.18 (Mar 24) to 12.70, marking a decrease of 5.48.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 1.00, marking an increase of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.69. It has decreased from 31.59 (Mar 24) to 19.69, marking a decrease of 11.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.64. This value is within the healthy range. It has decreased from 8.94 (Mar 24) to 3.64, marking a decrease of 5.30.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.24. This value is within the healthy range. It has decreased from 8.26 (Mar 24) to 3.24, marking a decrease of 5.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.23. This value is within the healthy range. It has decreased from 3.97 (Mar 24) to 3.23, marking a decrease of 0.74.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 2.13, marking an increase of 1.99.
- For PBDIT Margin (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has decreased from 28.28 (Mar 24) to 18.48, marking a decrease of 9.80.
- For PBIT Margin (%), as of Mar 25, the value is 16.46. This value is within the healthy range. It has decreased from 26.14 (Mar 24) to 16.46, marking a decrease of 9.68.
- For PBT Margin (%), as of Mar 25, the value is 16.43. This value is within the healthy range. It has increased from 12.56 (Mar 24) to 16.43, marking an increase of 3.87.
- For Net Profit Margin (%), as of Mar 25, the value is 10.82. This value exceeds the healthy maximum of 10. It has increased from 0.44 (Mar 24) to 10.82, marking an increase of 10.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.79. This value is within the healthy range. It has increased from 0.78 (Mar 24) to 16.79, marking an increase of 16.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 37.65 (Mar 24) to 17.19, marking a decrease of 20.46.
- For Return On Assets (%), as of Mar 25, the value is 10.39. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 10.39, marking an increase of 9.77.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. It has increased from 0.13 (Mar 24) to 0.39, marking an increase of 0.26.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. It has increased from 0.13 (Mar 24) to 0.39, marking an increase of 0.26.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.75 (Mar 24) to 1.14, marking a decrease of 0.61.
- For Current Ratio (X), as of Mar 25, the value is 10.62. This value exceeds the healthy maximum of 3. It has decreased from 31.14 (Mar 24) to 10.62, marking a decrease of 20.52.
- For Quick Ratio (X), as of Mar 25, the value is 10.62. This value exceeds the healthy maximum of 2. It has decreased from 31.14 (Mar 24) to 10.62, marking a decrease of 20.52.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 37.51. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.51, marking an increase of 37.51.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.61. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 31.61, marking an increase of 31.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is 62.49. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 62.49, marking an increase of 62.49.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.39. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 68.39, marking an increase of 68.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 568.86. This value is within the healthy range. It has increased from 202.15 (Mar 24) to 568.86, marking an increase of 366.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 334.18. This value is within the healthy range. It has increased from 100.28 (Mar 24) to 334.18, marking an increase of 233.90.
- For Enterprise Value (Cr.), as of Mar 25, the value is 41.82. It has decreased from 65.99 (Mar 24) to 41.82, marking a decrease of 24.17.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.18. This value exceeds the healthy maximum of 3. It has decreased from 9.72 (Mar 24) to 6.18, marking a decrease of 3.54.
- For EV / EBITDA (X), as of Mar 25, the value is 33.41. This value exceeds the healthy maximum of 15. It has decreased from 34.36 (Mar 24) to 33.41, marking a decrease of 0.95.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.41. This value exceeds the healthy maximum of 3. It has decreased from 9.97 (Mar 24) to 6.41, marking a decrease of 3.56.
- For Retention Ratios (%), as of Mar 25, the value is 62.48. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 62.48, marking an increase of 62.48.
- For Price / BV (X), as of Mar 25, the value is 9.94. This value exceeds the healthy maximum of 3. It has decreased from 17.32 (Mar 24) to 9.94, marking a decrease of 7.38.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.41. This value exceeds the healthy maximum of 3. It has decreased from 9.97 (Mar 24) to 6.41, marking a decrease of 3.56.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AccelerateBS India Ltd:
- Net Profit Margin: 10.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.19% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.79% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 334.18
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 10.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.5 (Industry average Stock P/E: 47.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 604, Quantum Tower, Mumbai Maharashtra 400064 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kunal Arvind Shah | Chairman & Managing Director |
| Mr. Keyur Dipakkumar Shah | Whole Time Director |
| Ms. Ami Keyur Shah | Executive Director & CFO |
| Ms. Ishani Kunal Shah | Executive Director |
| Mr. Krunal Bhupendra Katwala | Ind. Non-Executive Director |
| Mr. Pratik Pravin Doshi | Ind. Non-Executive Director |
| Mr. Hardik Naresh Bagadia | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of AccelerateBS India Ltd?
AccelerateBS India Ltd's intrinsic value (as of 08 January 2026) is ₹39.57 which is 49.91% lower the current market price of ₹79.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹27.2 Cr. market cap, FY2025-2026 high/low of ₹165/67.0, reserves of ₹1.73 Cr, and liabilities of ₹6.65 Cr.
What is the Market Cap of AccelerateBS India Ltd?
The Market Cap of AccelerateBS India Ltd is 27.2 Cr..
What is the current Stock Price of AccelerateBS India Ltd as on 08 January 2026?
The current stock price of AccelerateBS India Ltd as on 08 January 2026 is ₹79.0.
What is the High / Low of AccelerateBS India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AccelerateBS India Ltd stocks is ₹165/67.0.
What is the Stock P/E of AccelerateBS India Ltd?
The Stock P/E of AccelerateBS India Ltd is 18.5.
What is the Book Value of AccelerateBS India Ltd?
The Book Value of AccelerateBS India Ltd is 15.0.
What is the Dividend Yield of AccelerateBS India Ltd?
The Dividend Yield of AccelerateBS India Ltd is 1.27 %.
What is the ROCE of AccelerateBS India Ltd?
The ROCE of AccelerateBS India Ltd is 22.2 %.
What is the ROE of AccelerateBS India Ltd?
The ROE of AccelerateBS India Ltd is 17.6 %.
What is the Face Value of AccelerateBS India Ltd?
The Face Value of AccelerateBS India Ltd is 10.0.